Prevalence of temporomandibular disorders diagnosis in patients treated with Herbst appliance: a systematic review and meta-analysis

G Minervini, M Di Blasio, R Franco, MM Marrapodi… - BMC Oral Health, 2024 - Springer
Abstract Background The Herbst appliance is an excellent therapy for treating class II
malocclusions with increased overjet. Its mechanics involve propelling the mandibular bone …

Botulinum toxin-A effects on pain, somatosensory and psychosocial features of patients with refractory masticatory myofascial pain: a randomized double-blind clinical …

G De la Torre Canales, RL Poluha, LR Bonjardim… - Scientific Reports, 2024 - nature.com
The antinociceptive effect of BoNT-A have been well documented in animal studies;
however, results of few but well-designed randomized placebo-controlled clinical trials …

Noninvasive interventions for temporomandibular disorders: a scoping review of systematic reviews from 2017 to 2022.

AU Yap, M Wan Yong Tan… - Quintessence …, 2023 - search.ebscohost.com
Objectives: This scoping review assessed systematic reviews on noninvasive
temporomandibular disorder therapies to identify evidence gaps and formulate clinical …

Botulinum toxin and percutaneous needle electrolysis for the treatment of chronic masticatory myalgia

LM Gonzalez-Perez, R Vera-Martin, E Montes-Latorre… - Toxins, 2023 - mdpi.com
Botulinum toxin type A (BTA) is applied in muscle hyperactivity disorders and injected into
affected muscles, producing deep and persistent muscle relaxation. Several …

Outcomes of incobotulinumtoxinA injection on myalgia and arthralgia in patients undergoing temporomandibular joint arthroscopy: a randomized controlled trial

DF Ângelo, D Sanz, F Maffia, HJ Cardoso - Toxins, 2023 - mdpi.com
Background: Several studies have considered Botulinum Neurotoxin Type A injections
effective in treating temporomandibular joint disorder (TMD) symptoms. A double-blind …

Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis

N Cinone, L Santoro, S Spina, S Facciorusso… - Toxins, 2022 - mdpi.com
Background: The present study aimed to evaluate the reasons and determinants of BoNT-A
discontinuation in patients with stroke, multiple sclerosis, spinal cord injury, and traumatic …

Effect of botulinum toxin type A on muscular temporomandibular disorder: A systematic review and meta‐analysis of randomized controlled trials

K Li, K Tan, A Yacovelli, WG Bi - Journal of Oral Rehabilitation, 2024 - Wiley Online Library
Background Botulinum toxin type A (BTX‐A) is increasingly used to manage painful
temporomandibular disorders (TMD). However, the effect of BTX‐A on muscular TMD …

Temporomandibular Disorders Management—What's New? A Scoping Review

G Mauro, A Verdecchia, C Suárez-Fernández… - Dentistry Journal, 2024 - mdpi.com
Temporomandibular disorders include various conditions that impact the masticatory
system, affecting its structure, function, or physiology. Clinicians face a complex array of …

Botulinum Toxin-A for the Treatment of Myogenous Temporomandibular Disorders: An Umbrella Review of Systematic Reviews

G De la Torre Canales, MB Câmara-Souza, M Ernberg… - Drugs, 2024 - Springer
Abstract Objective Temporomandibular disorders (TMDs) encompass several conditions that
cause pain and impair function of the masticatory muscles (M-TMDs) and …

[HTML][HTML] Occlusal splint or botulinum toxin-A for jaw muscle pain treatment in probable sleep bruxism: a randomized controlled trial

LA Chisini, ALC Pires, V Poletto-Neto, MF Damian… - Journal of Dentistry, 2024 - Elsevier
Objectives To conduct an equivalency randomized controlled trial comparing occlusal splint
(OS) and botulinum toxin-A (BTX-A) on jaw muscle pain in probable sleep bruxism. Methods …